Brief: Salarius Pharmaceuticals Presents Sp-3164 Preclinical Data At The Inaugural Molecular Glue Drug Development Summit

Decoy Therapeutics

27/01/2023 14:13

Jan 27 (Reuters) - Salarius Pharmaceuticals Inc
 SLRX.O :
    * SALARIUS PHARMACEUTICALS PRESENTS SP-3164 PRECLINICAL DATA
AT
THE INAUGURAL MOLECULAR GLUE DRUG DEVELOPMENT SUMMIT
    * SALARIUS PHARMACEUTICALS INC - PLANS TO SUBMIT
INVESTIGATIONAL
NEW DRUG APPLICATION TO FDA AND BEGIN A PHASE 1 TRIAL IN 2023

Source text for Eikon:  ID:nGNXbcsHyc 
Further company coverage:  SLRX.O 
 ((Reuters.Briefs@thomsonreuters.com;;))